4IOU | pdb_00004iou

Crystal structure of the HIV-1 Vif binding, catalytically active domain of APOBEC3F


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.75 Å
  • R-Value Free: 
    0.233 (Depositor), 0.235 (DCC) 
  • R-Value Work: 
    0.193 (Depositor), 0.194 (DCC) 
  • R-Value Observed: 
    0.195 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 4IOU

This is version 1.4 of the entry. See complete history

Literature

Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain.

Bohn, M.F.Shandilya, S.M.Albin, J.S.Kouno, T.Anderson, B.D.McDougle, R.M.Carpenter, M.A.Rathore, A.Evans, L.Davis, A.N.Zhang, J.Lu, Y.Somasundaran, M.Matsuo, H.Harris, R.S.Schiffer, C.A.

(2013) Structure 21: 1042-1050

  • DOI: https://doi.org/10.1016/j.str.2013.04.010
  • Primary Citation Related Structures: 
    4IOU

  • PubMed Abstract: 

    Human APOBEC3F is an antiretroviral single-strand DNA cytosine deaminase, susceptible to degradation by the HIV-1 protein Vif. In this study the crystal structure of the HIV Vif binding, catalytically active, C-terminal domain of APOBEC3F (A3F-CTD) was determined. The A3F-CTD shares structural motifs with portions of APOBEC3G-CTD, APOBEC3C, and APOBEC2. Residues identified to be critical for Vif-dependent degradation of APOBEC3F all fit within a predominantly negatively charged contiguous region on the surface of A3F-CTD. Specific sequence motifs, previously shown to play a role in Vif susceptibility and virion encapsidation, are conserved across APOBEC3s and between APOBEC3s and HIV-1 Vif. In this structure these motifs pack against each other at intermolecular interfaces, providing potential insights both into APOBEC3 oligomerization and Vif interactions.


  • Organizational Affiliation
    • Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Macromolecule Content 

  • Total Structure Weight: 93.11 kDa 
  • Atom Count: 5,668 
  • Modeled Residue Count: 713 
  • Deposited Residue Count: 796 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
DNA dC->dU-editing enzyme APOBEC-3F
A, B, C, D
199Homo sapiensMutation(s): 11 
Gene Names: APOBEC3F
EC: 3.5.4 (PDB Primary Data), 3.5.4.38 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for Q8IUX4 (Homo sapiens)
Explore Q8IUX4 
Go to UniProtKB:  Q8IUX4
PHAROS:  Q8IUX4
GTEx:  ENSG00000128394 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ8IUX4
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.75 Å
  • R-Value Free:  0.233 (Depositor), 0.235 (DCC) 
  • R-Value Work:  0.193 (Depositor), 0.194 (DCC) 
  • R-Value Observed: 0.195 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 50.79α = 110.75
b = 66.91β = 94.41
c = 75.64γ = 108.83
Software Package:
Software NamePurpose
PHENIXrefinement
PHASERphasing
REFMACrefinement
HKL-2000data reduction
HKL-2000data scaling
Locallydata collection

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2013-05-29
    Type: Initial release
  • Version 1.1: 2013-06-19
    Changes: Database references, Other, Refinement description
  • Version 1.2: 2013-07-03
    Changes: Database references
  • Version 1.3: 2019-07-17
    Changes: Data collection, Refinement description
  • Version 1.4: 2023-09-20
    Changes: Data collection, Database references, Derived calculations, Refinement description